123 related articles for article (PubMed ID: 23999221)
1. A comparison of screen and ram extrusion-spheronisation of simple pharmaceutical pastes based on microcrystalline cellulose.
Zhang M; Wilson DI; Ward R; Seiler C; Rough SL
Int J Pharm; 2013 Nov; 456(2):489-98. PubMed ID: 23999221
[TBL] [Abstract][Full Text] [Related]
2. A comparison of ram extrusion by single-holed and multi-holed dies for extrusion-spheronisation of microcrystalline-based pastes.
Zhang M; Rough SL; Ward R; Seiler C; Wilson DI
Int J Pharm; 2011 Sep; 416(1):210-22. PubMed ID: 21742021
[TBL] [Abstract][Full Text] [Related]
3. Non-aqueous formulations for ram and screen extrusion-spheronisation.
Zhang M; Rough SL; Ward R; Seiler C; Wilson DI
Int J Pharm; 2019 Apr; 560():394-405. PubMed ID: 30763682
[TBL] [Abstract][Full Text] [Related]
4. The production of homogeneous extrudates of microcrystalline cellulose pastes.
Rough SL; Wilson DI
Int J Pharm; 2004 May; 276(1-2):185-9. PubMed ID: 15113625
[TBL] [Abstract][Full Text] [Related]
5. A novel lab-scale screen extruder for studying extrusion-spheronisation.
Zhang M; Mascia S; Rough SL; Ward R; Seiler C; Wilson DI
Int J Pharm; 2013 Oct; 455(1-2):285-97. PubMed ID: 23871735
[TBL] [Abstract][Full Text] [Related]
6. Effects of liquid phase migration on extrusion of microcrystalline cellulose pastes.
Rough SL; Bridgwater J; Wilson DI
Int J Pharm; 2000 Aug; 204(1-2):117-26. PubMed ID: 11011994
[TBL] [Abstract][Full Text] [Related]
7. The effect of mixing on the extrusion-spheronisation of a micro-crystalline cellulose paste.
Bryan MP; Kent MD; Rickenbach J; Rimmer G; Wilson DI; Rough SL
Int J Pharm; 2015 Feb; 479(1):1-10. PubMed ID: 25528365
[TBL] [Abstract][Full Text] [Related]
8. Water movement evaluation during extrusion of wet powder masses by collecting extrudate fractions.
Tomer G; Newton JM
Int J Pharm; 1999 May; 182(1):71-7. PubMed ID: 10332076
[TBL] [Abstract][Full Text] [Related]
9. Extrusion-spheronisation of microcrystalline cellulose pastes using a non-aqueous liquid binder.
Mascia S; Seiler C; Fitzpatrick S; Wilson DI
Int J Pharm; 2010 Apr; 389(1-2):1-9. PubMed ID: 20123008
[TBL] [Abstract][Full Text] [Related]
10. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
11. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
Chatchawalsaisin J; Podczeck F; Newton JM
Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
[TBL] [Abstract][Full Text] [Related]
12. Extrusion-spheronisation of highly loaded 5-ASA multiparticulate dosage forms.
Di Pretoro G; Zema L; Gazzaniga A; Rough SL; Wilson DI
Int J Pharm; 2010 Dec; 402(1-2):153-64. PubMed ID: 20934502
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization.
Podczeck F; Knight PE; Newton JM
Int J Pharm; 2008 Feb; 350(1-2):145-54. PubMed ID: 17905548
[TBL] [Abstract][Full Text] [Related]
14. Liquid phase migration in the extrusion and squeezing of microcrystalline cellulose pastes.
Mascia S; Patel MJ; Rough SL; Martin PJ; Wilson DI
Eur J Pharm Sci; 2006 Sep; 29(1):22-34. PubMed ID: 16766162
[TBL] [Abstract][Full Text] [Related]
15. Properties of microcrystalline cellulose and powder cellulose after extrusion/spheronization as studied by fourier transform Raman spectroscopy and environmental scanning electron microscopy.
Fechner PM; Wartewig S; Füting M; Heilmann A; Neubert RH; Kleinebudde P
AAPS PharmSci; 2003 Nov; 5(4):E31. PubMed ID: 15198519
[TBL] [Abstract][Full Text] [Related]
16. Investigation on the co-extrudability and spheronization properties of wet masses.
Pinto JF; Lameiro MH; Martins P
Int J Pharm; 2001 Oct; 227(1-2):71-80. PubMed ID: 11564542
[TBL] [Abstract][Full Text] [Related]
17. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
18. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
19. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation.
Lustig-Gustafsson C; Kaur Johal H; Podczeck F; Newton JM
Eur J Pharm Sci; 1999 May; 8(2):147-52. PubMed ID: 10210738
[TBL] [Abstract][Full Text] [Related]
20. The evaluation of the rheological properties of lactose/microcrystalline cellulose and water mixtures by controlled stress rheometry and the relationship to the production of spherical pellets by extrusion/spheronization.
MacRitchie KA; Newton JM; Rowe RC
Eur J Pharm Sci; 2002 Oct; 17(1-2):43-50. PubMed ID: 12356419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
